Shannon M Conley Selected Research

Cochlear Diseases

1/2021

Gene Therapy to the Retina and the Cochlea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shannon M Conley Research Topics

Disease

28	Retinal Degeneration 01/2022 - 01/2009
10	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2020 - 01/2009
9	Retinal Diseases 01/2021 - 01/2010
5	Macular Degeneration (Age-Related Maculopathy) 10/2018 - 02/2010
3	Cone-Rod Dystrophies 10/2020 - 01/2016
3	Blindness (Hysterical Blindness) 10/2014 - 09/2010
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Inflammation (Inflammations) 09/2021 - 10/2004
2	Stargardt Disease 01/2016 - 09/2012
2	congenital stationary Night blindness 01/2016 - 06/2015
2	Glaucoma 04/2006 - 02/2004
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Cochlear Diseases 01/2021
1	Phototoxic Dermatitis (Phototoxicity) 01/2020
1	Cognitive Dysfunction 01/2019
1	Hypertrophy 01/2019
1	Cerebral Hemorrhage 01/2019
1	Hypoxia (Hypoxemia) 01/2016
1	Night Blindness (Nyctalopia) 01/2016
1	Vitelliform Macular Dystrophy 04/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2013
1	Microaneurysm 01/2013
1	Hyperglycemia 01/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013
1	Enhanced S-Cone Syndrome 01/2013
1	Ocular Hypertension (Glaucoma, Suspect) 04/2006
1	Starvation 10/2005

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2020 - 02/2010
10	PeripherinsIBA 10/2020 - 06/2014
10	TetraspaninsIBA 01/2020 - 01/2010
6	Retinaldehyde (Retinal)IBA 01/2022 - 01/2013
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2005
4	Rhodopsin (Visual Purple)IBA 10/2020 - 06/2015
3	Glycoproteins (Glycoprotein)IBA 01/2016 - 01/2010
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 01/2019
2	riboflavin-binding proteinIBA 10/2020 - 01/2020
2	AntioxidantsIBA 01/2016 - 10/2014
2	Codon (Codons)IBA 01/2016 - 02/2010
2	DisulfidesIBA 12/2010 - 03/2009
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2010 - 03/2009
2	SeleniumIBA 04/2006 - 02/2004
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	tyrosine O-sulfateIBA 09/2021
1	Flavin-Adenine Dinucleotide (FAD)IBA 10/2020
1	Flavin Mononucleotide (FMN)IBA 10/2020
1	Riboflavin (Vitamin B2)FDA LinkGeneric 10/2020
1	FlavinsIBA 01/2020
1	Angiotensin IIIBA 01/2019
1	ElastinIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	LipidsIBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	PolylysineIBA 01/2018
1	Cyclic Nucleotide-Gated Cation ChannelsIBA 03/2016
1	Catalytic RNA (Ribozymes)IBA 01/2016
1	Free RadicalsIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	SNARE Proteins (SNAREs)IBA 01/2015
1	yttria (yttrium oxide)IBA 10/2014
1	Retinal Pigments (Pigments, Visual)IBA 06/2014
1	Mutant Proteins (Protein, Mutant)IBA 12/2013
1	Biological ProductsIBA 01/2013
1	Cysteine (L-Cysteine)FDA Link 12/2010
1	OpsinsIBA 04/2010
1	Interleukin-10 (Interleukin 10)IBA 10/2004
1	Matrix Metalloproteinases (MMPs)IBA 02/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 04/2010
1	Intravitreal Injections 09/2021